Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Mycobacterium bolletii Lung Disease in Cystic Fibrosis.

Rollet-Cohen V, Roux AL, Le Bourgeois M, Sapriel G, El Bahri M, Jais JP, Heym B, Mougari F, Raskine L, Véziris N, Gaillard JL, Sermet-Gaudelus I.

Chest. 2019 Mar 29. pii: S0012-3692(19)30747-0. doi: 10.1016/j.chest.2019.03.019. [Epub ahead of print]

PMID:
30935892
2.

Predictive factors for lumacaftor/ivacaftor clinical response.

Masson A, Schneider-Futschik EK, Baatallah N, Nguyen-Khoa T, Girodon E, Hatton A, Flament T, Le Bourgeois M, Chedevergne F, Bailly C, Kyrilli S, Achimastos D, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

J Cyst Fibros. 2019 May;18(3):368-374. doi: 10.1016/j.jcf.2018.12.011. Epub 2018 Dec 28.

PMID:
30595473
3.

Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?

Pranke I, Hatton A, Masson A, Flament T, Le Bourgeois M, Chedevergne F, Bailly C, Urbach V, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):123-126. doi: 10.1164/rccm.201808-1436LE. No abstract available.

PMID:
30326728
4.

Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening.

Sermet-Gaudelus I, Brouard J, Audrézet MP, Couderc Kohen L, Weiss L, Wizla N, Vrielynck S, LLerena K, Le Bourgeois M, Deneuville E, Remus N, Nguyen-Khoa T, Raynal C, Roussey M, Girodon E.

Arch Pediatr. 2017 Dec;24(12):e1-e14. doi: 10.1016/j.arcped.2017.07.015. Epub 2017 Nov 22.

PMID:
29174009
5.

Early follow-up of lung disease in infants with cystic fibrosis using the raised volume rapid thoracic compression technique and computed tomography during quiet breathing.

Gauthier R, Cabon Y, Giroux-Metges MA, Du Boisbaudry C, Reix P, Le Bourgeois M, Chiron R, Molinari N, Saguintaah M, Amsallem F, Matecki S.

Pediatr Pulmonol. 2017 Oct;52(10):1283-1290. doi: 10.1002/ppul.23786. Epub 2017 Sep 1.

PMID:
28861941
6.

[Management of infants whose diagnosis is inconclusive at neonatal screening for cystic fibrosis].

Sermet-Gaudelus I, Brouard J, Audrézet MP, Couderc Kohen L, Weiss L, Wizla N, Vrielynck S, LLerena K, Le Bourgeois M, Deneuville E, Remus N, Nguyen-Khoa T, Raynal C, Roussey M, Girodon E.

Arch Pediatr. 2017 Apr;24(4):401-414. doi: 10.1016/j.arcped.2017.01.019. Epub 2017 Mar 1. French.

PMID:
28258861
7.

A simplified, semi-quantitative structural lung disease computed tomography outcome during quiet breathing in infants with cystic fibrosis.

Saguintaah M, Cabon Y, Gauthier R, Duboibaudry C, Couderc L, Le Bourgeois M, Reix P, Chiron R, Arrada IT, Molinari N, Matecki S.

J Cyst Fibros. 2017 Jan;16(1):151-157. doi: 10.1016/j.jcf.2016.10.014. Epub 2016 Nov 23.

8.

Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.

Mesbahi M, Shteinberg M, Wilschanski M, Hatton A, Nguyen-Khoa T, Friedman H, Cohen M, Escabasse V, Le Bourgeois M, Lucidi V, Sermet-Gaudelus I, Bassinet L, Livnat G.

J Cyst Fibros. 2017 Jan;16(1):45-48. doi: 10.1016/j.jcf.2016.08.006. Epub 2016 Sep 20.

9.

Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.

Frémond ML, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, Bessis D, Cros G, Rice GI, Charbit B, Hulin A, Khoudour N, Caballero CM, Bodemer C, Fabre M, Berteloot L, Le Bourgeois M, Reix P, Walzer T, Moshous D, Blanche S, Fischer A, Bader-Meunier B, Rieux-Laucat F, Crow YJ, Neven B.

J Allergy Clin Immunol. 2016 Dec;138(6):1752-1755. doi: 10.1016/j.jaci.2016.07.015. Epub 2016 Aug 20. No abstract available.

10.

Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study.

Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, Fayon MJ, Delacourt C, Ligier C, Watier L, Guillemot D; Children, Antibiotics, Nonsteroidal Anti-inflammatory Drugs and Childhood Empyema (ChANCE) Study Group.

J Pediatr. 2016 Aug;175:47-53.e3. doi: 10.1016/j.jpeds.2016.05.025. Epub 2016 Jun 20.

PMID:
27339249
11.

Bioelectrical impedance in young patients with cystic fibrosis: Validation of a specific equation and clinical relevance.

Charatsi AM, Dusser P, Freund R, Maruani G, Rossin H, Boulier A, Le Bourgeois M, Chedevergne F, de Blic J, Letourneur A, Casimir G, Jais JP, Sermet-Gaudelus I.

J Cyst Fibros. 2016 Nov;15(6):825-833. doi: 10.1016/j.jcf.2016.05.004. Epub 2016 Jun 9.

12.

Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment.

Giovannini-Chami L, Blanc S, Hadchouel A, Baruchel A, Boukari R, Dubus JC, Fayon M, Le Bourgeois M, Nathan N, Albertini M, Clément A, de Blic J.

Pediatr Pulmonol. 2016 Feb;51(2):203-16. doi: 10.1002/ppul.23368. Epub 2015 Dec 30. Review.

PMID:
26716396
13.

Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype.

El Khatib N, Ferroni A, Le Bourgeois M, Chedevergne F, Clairicia M, Avril H, Guiso N, Sermet-Gaudelus I.

J Cyst Fibros. 2015 Sep;14(5):E13-5. doi: 10.1016/j.jcf.2015.03.014. Epub 2015 Apr 18.

14.

Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?

Matecki S, Kent L, de Boeck K, Le Bourgeois M, Zielen S, Braggion C, Arets HG, Bradley J, Davis S, Sermet I, Reix P; respiratory function group of the European Cystic Fibrosis Society Clinical Trial Network.

J Cyst Fibros. 2016 Jan;15(1):10-20. doi: 10.1016/j.jcf.2015.03.015. Epub 2015 Apr 15. Review.

15.

Technical and practical issues for tidal breathing measurements of nasal nitric oxide in children.

Beydon N, Chambellan A, Alberti C, de Blic J, Clément A, Escudier E, Le Bourgeois M.

Pediatr Pulmonol. 2015 Dec;50(12):1374-82. doi: 10.1002/ppul.23167. Epub 2015 Mar 2.

PMID:
25731630
16.

Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study.

Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF.

J Cyst Fibros. 2015 Jan;14(1):97-103. doi: 10.1016/j.jcf.2014.05.015. Epub 2014 Aug 5.

17.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL; OMA group.

J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30.

18.

Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.

Halphen I, Elie C, Brousse V, Le Bourgeois M, Allali S, Bonnet D, de Montalembert M.

PLoS One. 2014 May 30;9(5):e97462. doi: 10.1371/journal.pone.0097462. eCollection 2014.

19.

[Recommendations for the use of diagnostic testing in low respiratory infections in children older than three months].

Houdouin V, Pouessel G, Angoulvant F, Brouard J, Derelle J, Fayon M, Ferroni A, Gangneux JP, Hau I, Le Bourgeois M, Lorrot M, Menotti J, Nathan N, Vabret A, Wallet F, Bonacorsi S, Cohen R, de Blic J, Deschildre A, Gandemer V, Pin I, Labbe A, Le Roux P, Martinot A, Rammaert B; Groupe de recherche sur les avancées en pneumo-pédiatrie (GRAPP), Dubus JC, Delacourt C, Marguet C.

Arch Pediatr. 2014 Apr;21(4):418-23. doi: 10.1016/j.arcped.2014.01.004. Epub 2014 Mar 7. French. Erratum in: Arch Pediatr. 2014 Aug;21(8):905. Rammaert, S [corrected to Rammaert, B].

PMID:
24613479
20.

Primary pulmonary alveolar proteinosis: computed tomography features at diagnosis.

Berteloot L, Taam RA, Emond-Gonsard S, Mamou-Mani T, Lambot K, Grévent D, Elie C, Le Bourgeois M, Delacourt C, Brunelle F, de Blic J.

Pediatr Radiol. 2014 Jul;44(7):795-802. doi: 10.1007/s00247-014-2888-1. Epub 2014 Mar 6.

PMID:
24599270
21.

Regarding the article entitled "hypersensitivity to antibiotics in patients with cystic fibrosis".

Matar R, Le Bourgeois M, Scheinmann P, de Blic J, Ponvert C.

J Cyst Fibros. 2014 Mar;13(2):238-9. doi: 10.1016/j.jcf.2013.12.008. Epub 2014 Jan 10. No abstract available.

22.

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion C, Lever S, Arets HG, Brownlee K, Bradley JM, Bayfield K, O'Neill K, Savi D, Bilton D, Lindblad A, Davies JC, Sermet I, De Boeck K; European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee.

J Cyst Fibros. 2014 Mar;13(2):123-38. doi: 10.1016/j.jcf.2013.09.005. Epub 2013 Dec 5. Review.

23.

Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy.

Matar R, Le Bourgeois M, Scheinmann P, de Blic J, Ponvert C.

Pediatr Allergy Immunol. 2014 Feb;25(1):88-93. doi: 10.1111/pai.12154. Epub 2013 Nov 18.

PMID:
24237053
24.

Lung manifestations in MPO-ANCA associated vasculitides in children.

Ben Ameur S, Niaudet P, Baudouin V, Le Bourgeois M, Houdouin V, Delacourt C, Hadchouel A.

Pediatr Pulmonol. 2014 Mar;49(3):285-90. doi: 10.1002/ppul.22793. Epub 2013 Mar 26.

PMID:
23532899
25.

Asphyxiating thoracic dysplasia: clinical and molecular review of 39 families.

Baujat G, Huber C, El Hokayem J, Caumes R, Do Ngoc Thanh C, David A, Delezoide AL, Dieux-Coeslier A, Estournet B, Francannet C, Kayirangwa H, Lacaille F, Le Bourgeois M, Martinovic J, Salomon R, Sigaudy S, Malan V, Munnich A, Le Merrer M, Le Quan Sang KH, Cormier-Daire V.

J Med Genet. 2013 Feb;50(2):91-8. doi: 10.1136/jmedgenet-2012-101282.

PMID:
23339108
26.

Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.

Hubert D, Réglier-Poupet H, Sermet-Gaudelus I, Ferroni A, Le Bourgeois M, Burgel PR, Serreau R, Dusser D, Poyart C, Coste J.

J Cyst Fibros. 2013 Sep;12(5):497-503. doi: 10.1016/j.jcf.2012.12.003. Epub 2013 Jan 3.

27.

The lung is involved in juvenile dermatomyositis.

Pouessel G, Deschildre A, Le Bourgeois M, Cuisset JM, Catteau B, Karila C, Nève V, Thumerelle C, Quartier P, Tillie-Leblond I.

Pediatr Pulmonol. 2013 Oct;48(10):1016-25. doi: 10.1002/ppul.22742. Epub 2012 Dec 31.

PMID:
23281200
28.

Respiratory outcome in children with scimitar syndrome.

Chemin A, Bonnet D, Le Bourgeois M, Levy M, Delacourt C; Respiratory Outcome in Scimitar Syndrome Collaborators.

J Pediatr. 2013 Feb;162(2):275-9.e1. doi: 10.1016/j.jpeds.2012.07.066. Epub 2012 Sep 14.

PMID:
22985724
29.

Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.

Catherinot E, Roux AL, Vibet MA, Bellis G, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard JL; OMA group.

Eur Respir J. 2013 May;41(5):1101-6. doi: 10.1183/09031936.00065612. Epub 2012 Aug 30.

30.

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.

Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard JL; OMA group.

J Cyst Fibros. 2013 Jan;12(1):74-80. doi: 10.1016/j.jcf.2012.06.009. Epub 2012 Jul 31.

31.

Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.

Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, Thumerelle C, Oksenhendler E, Boutboul D, Thomas C, Hoarau C, Lebranchu Y, Stephan JL, Cazorla C, Aladjidi N, Micheau M, Tron F, Baruchel A, Barlogis V, Palenzuela G, Mathey C, Dominique S, Body G, Munzer M, Fouyssac F, Jaussaud R, Bader-Meunier B, Mahlaoui N, Blanche S, Debré M, Le Bourgeois M, Gandemer V, Lambert N, Grandin V, Ndaga S, Jacques C, Harre C, Forveille M, Alyanakian MA, Durandy A, Bodemer C, Suarez F, Hermine O, Lortholary O, Casanova JL, Fischer A, Picard C.

Medicine (Baltimore). 2012 Jul;91(4):e1-19. doi: 10.1097/MD.0b013e31825f95b9.

32.

[The respiratory disease of cystic fibrosis, from infancy to childhood].

Hubert D, Le Bourgeois M.

Arch Pediatr. 2012 May;19 Suppl 1:S17-9. doi: 10.1016/S0929-693X(12)71102-8. French.

PMID:
22682483
33.

[Fungal infections in cystic fibrosis].

Le Bourgeois M, Sermet I, Bailly-Botuha C, Delacourt C, de Blic J.

Arch Pediatr. 2011 May;18 Suppl 1:S15-21. doi: 10.1016/S0929-693X(11)70936-8. French.

PMID:
21596282
34.

Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.

Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, Scheinmann P, De Blic J.

Pediatr Allergy Immunol. 2011 Jun;22(4):411-8. doi: 10.1111/j.1399-3038.2011.01169.x. Epub 2011 Mar 30.

PMID:
21535179
35.

Characteristics of disorders associated with genetic mutations of surfactant protein C.

Thouvenin G, Abou Taam R, Flamein F, Guillot L, Le Bourgeois M, Reix P, Fayon M, Counil F, Depontbriand U, Feldmann D, Pointe HD, de Blic J, Clement A, Epaud R.

Arch Dis Child. 2010 Jun;95(6):449-54. doi: 10.1136/adc.2009.171553. Epub 2010 Apr 19.

PMID:
20403820
36.

[Management of pneumonia and pleuropneumonia in children].

Le Bourgeois M, Houdouin V.

Rev Mal Respir. 2009 Dec;26(10):1175-7. French. No abstract available.

PMID:
20032856
37.

Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity.

Mahut B, Trinquart L, Le Bourgeois M, Becquemin MH, Beydon N, Aubourg F, Jala M, Bidaud-Chevalier B, Dinh-Xuan AT, Randrianarivelo O, Denjean A, de Blic J, Delclaux C.

Allergy. 2010 May;65(5):636-44. doi: 10.1111/j.1398-9995.2009.02221.x. Epub 2009 Oct 20.

PMID:
19845572
38.

Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.

Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F.

Pediatr Pulmonol. 2009 Aug;44(8):820-5. doi: 10.1002/ppul.21076.

PMID:
19598278
39.

[Novel therapies for cystic fibrosis in 2009].

Sermet-Gaudelus I, Le Bourgeois M, Edelman A, Lenoir G.

Arch Pediatr. 2009 Jun;16(6):578-80. doi: 10.1016/S0929-693X(09)74073-4. French. No abstract available.

PMID:
19541091
40.

[The evolution of lung disease in children with cystic fibrosis].

Le Bourgeois M.

Arch Pediatr. 2009 Jun;16(6):576-7. doi: 10.1016/S0929-693X(09)74072-2. French. No abstract available.

PMID:
19541090
41.

New surfactant protein C gene mutations associated with diffuse lung disease.

Guillot L, Epaud R, Thouvenin G, Jonard L, Mohsni A, Couderc R, Counil F, de Blic J, Taam RA, Le Bourgeois M, Reix P, Flamein F, Clement A, Feldmann D.

J Med Genet. 2009 Jul;46(7):490-4. doi: 10.1136/jmg.2009.066829. Epub 2009 May 13. Erratum in: J Med Genet. 2010 Jul;47(7):485.

42.

Relationships between specific airway resistance and forced expiratory flows in asthmatic children.

Mahut B, Trinquart L, Bokov P, Le Bourgeois M, Waernessyckle S, Peiffer C, Delclaux C.

PLoS One. 2009;4(4):e5270. doi: 10.1371/journal.pone.0005270. Epub 2009 Apr 17.

43.

Familial interstitial disease with I73T mutation: A mid- and long-term study.

Abou Taam R, Jaubert F, Emond S, Le Bourgeois M, Epaud R, Karila C, Feldmann D, Scheinmann P, de Blic J.

Pediatr Pulmonol. 2009 Feb;44(2):167-75. doi: 10.1002/ppul.20970.

PMID:
19148933
44.

[Influenza vaccination coverage in asthmatic children in France in 2006-2007].

Rancé F, Chave C, de Blic J, Deschildre A, Donato L, Dubus JC, Fayon M, Labbe A, Le Bourgeois M, Llerena C, Le Manach G, Pin I, Santos C, Thumerelle C, Aubert M, Weil-Olivier C.

Arch Pediatr. 2008 Nov;15(11):1724-8. French.

PMID:
19090033
45.

Low influenza vaccination coverage in asthmatic children in France in 2006-7.

Rance F, Chave C, De Blic J, Deschildre A, Donato L, Dubus J, Fayon M, Labbe A, Le Bourgeois M, Llerena C, Le Manach G, Pin I, Santos C, Thumerelle C, Aubert M, Weil-Olivier C.

Euro Surveill. 2008 Oct 23;13(43). pii: 19016.

46.

Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care.

Duguépéroux I, Tamalet A, Sermet-Gaudelus I, Le Bourgeois M, Gérardin M, Desmazes-Dufeu N, Hubert D.

J Adolesc Health. 2008 Nov;43(5):459-65. doi: 10.1016/j.jadohealth.2008.03.005. Epub 2008 Jun 16.

PMID:
18848674
47.

Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases.

Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P.

Eur J Dermatol. 2008 Sep-Oct;18(5):561-5. doi: 10.1684/ejd.2008.0480. Epub 2008 Aug 8.

PMID:
18693161
48.

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.

Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A.

J Clin Microbiol. 2008 Oct;46(10):3361-7. doi: 10.1128/JCM.00569-08. Epub 2008 Aug 6.

49.

Bacterial contamination in the environment of hospitalised children with cystic fibrosis.

Ferroni A, Werkhauser-Bertrand A, Le Bourgeois M, Beauvais R, Vrielynck S, Durand C, Lenoir G, Berche P, Sermet-Gaudelus I.

J Cyst Fibros. 2008 Nov;7(6):477-82. doi: 10.1016/j.jcf.2008.05.001. Epub 2008 Jun 11.

50.

[Exercise alveolar hypoventilation in long-term survivors of bronchopulmonary dysplasia].

Karila C, Saulnier JP, Elie C, Taupin P, Scheinmann P, Le Bourgeois M, Waernessycle S, de Blic J.

Rev Mal Respir. 2008 Mar;25(3):303-12. French.

Supplemental Content

Loading ...
Support Center